| Ytd | 16.40% | |
| 1y | 12.37% |
| Open | 137.95 | Prev Close | 139.67 | Low | 137.91 | High | 142.39 | Mkt Cap | 6.02B |
| Vol | 644.17K | Avg Vol | 525.84K | EPS | -0.54 | P/E | N/A | Forward P/E | 12.97 |
| Beta | 0.81 | Short Ratio | 8.55 | Inst. Own | 114.67% | Dividend | 1.36 | Div Yield | 0.97 |
| Ex Div Date | 08-14 | Earning | 10-29 | 50-d Avg | 133.99 | 200-d Avg | 122.49 | 1yr Est | 153.54 |
TFX News
Bank of New York Mellon Corp purchased a new position in Teleflex Incorporated (NYSE: TFX) during th
TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while cur
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Pen
Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressur
Top Wall Street analysts upgraded and raised price targets for FLNC, DT, NVDA, SNOW, TFX, COIN, and
Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target
UBS analyst Patrick Wood maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target
Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the pri
Piper Sandler analyst Jason Bednar reiterates Teleflex (NYSE:TFX) with a Overweight and raises th
Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 analyst
Teleflex (NYSE:TFX) reported quarterly earnings of $1.76 per share which beat the analyst consensus